HLA-E and lymphoma: In contrast, the LMP-1 GSDPHLPTL and GGDPHLPPL variants, both frequently found in patients with symptomatic or asymptomatic EBV reactivations, but not in EBV+ lymphoma patients, showed only a low capacity to upregulate HLA-E on the surface of Raji cells (Figure 1E).